• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于球菌样形态的谜题:超越基础科学

The Puzzle of Coccoid Forms of : Beyond Basic Science.

作者信息

Ierardi Enzo, Losurdo Giuseppe, Mileti Alessia, Paolillo Rosa, Giorgio Floriana, Principi Mariabeatrice, Di Leo Alfredo

机构信息

Section of Gastroenterology, Department of Emergency and Organ Transplantation, University "Aldo Moro" of Bari, 70124 Bari, Italy.

Ph.D. Course in Organs and Tissues Transplantation and Cellular Therapies, Department of Emergency and Organ Transplantation, University "Aldo Moro" of Bari, 70124 Bari, Italy.

出版信息

Antibiotics (Basel). 2020 May 31;9(6):293. doi: 10.3390/antibiotics9060293.

DOI:10.3390/antibiotics9060293
PMID:32486473
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7345126/
Abstract

() may enter a non-replicative, non-culturable, low metabolically active state, the so-called coccoid form, to survive in extreme environmental conditions. Since coccoid forms are not susceptible to antibiotics, they could represent a cause of therapy failure even in the absence of antibiotic resistance, i.e., relapse within one year. Furthermore, coccoid forms may colonize and infect the gastric mucosa in animal models and induce specific antibodies in animals and humans. Their detection is hard, since they are not culturable. Techniques, such as electron microscopy, polymerase chain reaction, loop-mediated isothermal amplification, flow cytometry and metagenomics, are promising even if current evidence is limited. Among the options for the treatment, some strategies have been suggested, such as a very high proton pump inhibitor dose, high-dose dual therapy, -acetycysteine, linolenic acid and vonoprazan. These clinical, diagnostic and therapeutic uncertainties will represent fascinating challenges in the future.

摘要

()可能进入一种非复制、不可培养、低代谢活性状态,即所谓的球状体形式,以便在极端环境条件下生存。由于球状体形式对抗生素不敏感,即使不存在抗生素耐药性,它们也可能是治疗失败的原因,即在一年内复发。此外,球状体形式可能在动物模型中定植并感染胃黏膜,并在动物和人类中诱导特异性抗体。由于它们不可培养,因此很难检测到它们。即使目前的证据有限,电子显微镜、聚合酶链反应、环介导等温扩增、流式细胞术和宏基因组学等技术也很有前景。在治疗选择中,已经提出了一些策略,例如非常高剂量的质子泵抑制剂、高剂量双联疗法、乙酰半胱氨酸、亚麻酸和沃克拉唑。这些临床、诊断和治疗上的不确定性将在未来成为引人入胜的挑战。

相似文献

1
The Puzzle of Coccoid Forms of : Beyond Basic Science.关于球菌样形态的谜题:超越基础科学
Antibiotics (Basel). 2020 May 31;9(6):293. doi: 10.3390/antibiotics9060293.
2
Resuscitation of the Helicobacter pylori Coccoid Forms by Resuscitation Promoter Factor Obtained from Micrococcus Luteus.从藤黄微球菌中获得的复苏促进因子对幽门螺杆菌球形形式的复苏作用
Curr Microbiol. 2020 Sep;77(9):2093-2103. doi: 10.1007/s00284-020-02043-x. Epub 2020 Jun 5.
3
Coccoid Helicobacter pylori not culturable in vitro reverts in mice.体外不可培养的球形幽门螺杆菌在小鼠体内可恢复。
Microbiol Immunol. 1994;38(11):843-50. doi: 10.1111/j.1348-0421.1994.tb02136.x.
4
Helicobacter pylori-coccoid forms and biofilm formation.幽门螺杆菌——球形形态与生物膜形成
FEMS Immunol Med Microbiol. 2009 Jul;56(2):112-5. doi: 10.1111/j.1574-695X.2009.00556.x. Epub 2009 Apr 27.
5
Three Tests Used to Identify Non-Culturable Form of Helicobacter pylori in Water Samples.用于鉴定水样中幽门螺杆菌不可培养形式的三种检测方法。
Jundishapur J Microbiol. 2015 Apr 18;8(4):e16811. doi: 10.5812/jjm.8(4)2015.16811. eCollection 2015 Apr.
6
Mucoid and coccoid Helicobacter pylori with fast growth and antibiotic resistance.具有快速生长和抗药性的黏液型和球菌型幽门螺旋杆菌。
Helicobacter. 2020 Apr;25(2):e12678. doi: 10.1111/hel.12678. Epub 2019 Dec 26.
7
Plural transformation-processes from spiral to coccoid Helicobacter pylori and its viability.幽门螺杆菌从螺旋形到球形的多种转变过程及其生存能力。
J Infect. 2003 Jan;46(1):49-55. doi: 10.1053/jinf.2002.1047.
8
[Role of Helicobacter pylori coccoid forms in infection and recrudescence].[幽门螺杆菌球形形式在感染和复发中的作用]
Gastroenterol Hepatol. 2016 Jan;39(1):28-35. doi: 10.1016/j.gastrohep.2015.04.009. Epub 2015 Jun 15.
9
Research progress in the with viable non-culturable state.具有活的非可培养状态的研究进展。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021 Dec 28;46(12):1423-1429. doi: 10.11817/j.issn.1672-7347.2021.210197.
10
[Helicobacter pylori morphological forms and their potential role in the transmission of infection].[幽门螺杆菌的形态及其在感染传播中的潜在作用]
Postepy Hig Med Dosw (Online). 2014 Mar 4;68:219-29. doi: 10.5604/17322693.1092705.

引用本文的文献

1
2-oxoglutarate:acceptor oxidoreductase-catalyzed redox cycling effectively targets coccoid forms of Helicobacter pylori.2-氧代戊二酸:受体氧化还原酶催化的氧化还原循环有效地靶向幽门螺杆菌的球菌形态。
Nat Commun. 2025 Jul 29;16(1):6965. doi: 10.1038/s41467-025-62477-4.
2
Towards Effective Eradication: Emerging Therapies in the Wake of Antibiotic Resistance.迈向有效根除:抗生素耐药性背景下的新兴疗法
Int J Mol Sci. 2025 Jun 24;26(13):6064. doi: 10.3390/ijms26136064.
3
Antibiotic Resistance and Genetic Determinants of in Oman: Insights from Phenotypic and Whole-Genome Analysis.

本文引用的文献

1
Mucoid and coccoid Helicobacter pylori with fast growth and antibiotic resistance.具有快速生长和抗药性的黏液型和球菌型幽门螺旋杆菌。
Helicobacter. 2020 Apr;25(2):e12678. doi: 10.1111/hel.12678. Epub 2019 Dec 26.
2
Evidence of viable Helicobacter pylori and other bacteria of public health interest associated with free-living amoebae in lettuce samples by next generation sequencing and other molecular techniques.利用下一代测序和其他分子技术在生菜样本中发现与自由生活阿米巴相关的有活力的幽门螺旋杆菌和其他公共卫生关注的细菌。
Int J Food Microbiol. 2020 Apr 2;318:108477. doi: 10.1016/j.ijfoodmicro.2019.108477. Epub 2019 Dec 12.
3
阿曼抗生素耐药性及其遗传决定因素:来自表型和全基因组分析的见解
Int J Mol Sci. 2025 Jun 12;26(12):5628. doi: 10.3390/ijms26125628.
4
Role of Immunohistochemistry in the Histopathological Assessment of Inflamed Endoscopic Gastric Biopsies.免疫组织化学在炎症性内镜胃活检组织病理学评估中的作用
Korean J Helicobacter Up Gastrointest Res. 2024 Mar;24(1):45-51. doi: 10.7704/kjhugr.2023.0048. Epub 2024 Mar 8.
5
Association of epithelial and subepithelial distribution detected by immunohistochemistry in gastric biopsies and clinical outcomes of patients receiving proton pump inhibitors.通过免疫组织化学检测胃活检中上皮和上皮下分布与接受质子泵抑制剂治疗患者临床结局的相关性。
Biomed Rep. 2025 May 29;23(2):127. doi: 10.3892/br.2025.2005. eCollection 2025 Aug.
6
Anti-urease therapy: a targeted approach to mitigating antibiotic resistance in Helicobacter pylori while preserving the gut microflora.抗脲酶疗法:一种在保留肠道微生物群的同时减轻幽门螺杆菌抗生素耐药性的靶向方法。
Gut Pathog. 2025 May 28;17(1):37. doi: 10.1186/s13099-025-00708-1.
7
Real Way to Target Gram-Negative Pathogens: Discovery of a Novel Antibiotic Class.靶向革兰氏阴性病原体的真正方法:新型抗生素类别的发现
J Med Chem. 2025 May 22;68(10):10128-10138. doi: 10.1021/acs.jmedchem.5c00112. Epub 2025 Mar 31.
8
infection process: from the molecular world to clinical treatment.感染过程:从分子世界到临床治疗
Front Microbiol. 2025 Feb 27;16:1541140. doi: 10.3389/fmicb.2025.1541140. eCollection 2025.
9
Cholesterol Functionalized Nanoparticles Are Effective against Helicobacter pylori, the Gastric Bug: A Proof-of-Concept Study.胆固醇功能化纳米颗粒对胃部细菌幽门螺杆菌有效:一项概念验证研究
Adv Healthc Mater. 2025 Apr;14(10):e2404065. doi: 10.1002/adhm.202404065. Epub 2025 Feb 5.
10
Coccoid Helicobacter pylori in patients with obesity: an immunohistochemical study.肥胖患者中的球形幽门螺杆菌:一项免疫组织化学研究。
Virchows Arch. 2025 Feb 1. doi: 10.1007/s00428-025-04042-4.
Optimizing proton pump inhibitors in treatment: Old and new tricks to improve effectiveness.
优化质子泵抑制剂治疗:提高疗效的新老方法。
World J Gastroenterol. 2019 Sep 14;25(34):5097-5104. doi: 10.3748/wjg.v25.i34.5097.
4
Vonoprazan and Treatment: A Lesson From Japan or a Limited Geographic Phenomenon?沃克帕唑与治疗:源自日本的经验教训还是局限于特定地区的现象?
Front Pharmacol. 2019 Apr 5;10:316. doi: 10.3389/fphar.2019.00316. eCollection 2019.
5
Role of Vonoprazan in Eradication Therapy in Japan.沃克在日本根除治疗中的作用。
Front Pharmacol. 2019 Jan 15;9:1560. doi: 10.3389/fphar.2018.01560. eCollection 2018.
6
New fecal test for non-invasive detection: A diagnostic accuracy study.新型粪便检测方法可无创检测:一项诊断准确性研究。
World J Gastroenterol. 2018 Jul 21;24(27):3021-3029. doi: 10.3748/wjg.v24.i27.3021.
7
The "three-in-one" formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice.三联或四联铋剂疗法根除幽门螺杆菌治疗加或不加益生菌补充剂:日常临床实践中的疗效和安全性。
Helicobacter. 2018 Aug;23(4):e12502. doi: 10.1111/hel.12502. Epub 2018 Jun 20.
8
Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori.系统评价与荟萃分析:强效酸抑制剂——沃诺拉赞优于质子泵抑制剂,可根除克拉霉素耐药的幽门螺杆菌菌株。
Helicobacter. 2018 Aug;23(4):e12495. doi: 10.1111/hel.12495. Epub 2018 Jun 6.
9
Characterization of morphological conversion of Helicobacter pylori under anaerobic conditions.幽门螺杆菌在厌氧条件下形态转化的特征分析。
Microbiol Immunol. 2018 Apr;62(4):221-228. doi: 10.1111/1348-0421.12582.
10
Noninvasive molecular analysis of : Is it time for tailored first-line therapy?非侵入性分子分析:是时候进行个性化一线治疗了吗?
World J Gastroenterol. 2017 Apr 14;23(14):2453-2458. doi: 10.3748/wjg.v23.i14.2453.